Metabolite measures associated with cancer preventive behaviors included biomarkers of inflammation, insulin sensitivity, as well as cardiometabolic risk; aberrations in lipid classes, lipid concentrations in HDL, VLDL, TG subclasses, and lipid particle size. The gene discussed is INS; the disease is cancer.